<DOC>
	<DOCNO>NCT02941146</DOCNO>
	<brief_summary>Evaluate safety efficacy abdominal DualSculpting CoolAdvantage applicator .</brief_summary>
	<brief_title>DualSculpting Abdomen</brief_title>
	<detailed_description />
	<mesh_term>Lipid Metabolism Disorders</mesh_term>
	<criteria>Inclusion Criteria Male female subject &gt; 22 year age &lt; 65 year age . Subject assess eligible receive multiple DualSculpting treatment abdomen use CoolAdvantage and/or CoolAdvantage Plus applicator . No weight change exceed 5 % body weight precede month . Subject agree maintain his/her weight ( i.e. , within 5 % ) make major change diet exercise routine course study . Subject read sign study write informed consent form.. Exclusion Criteria Subject surgical procedure ( ) area intend treatmentSubject surgical procedure ( ) area intend treatment . Subject invasive fat reduction procedure ( e.g. , liposuction , mesotherapy ) area intend treatment . Subject noninvasive fat reduction and/or body contour procedure area intend treatment within past 12 month . Subject need administer , know history subcutaneous injection area intend treatment ( e.g. , heparin , insulin ) within past month . Subject known history cryoglobulinemia , cold urticaria , cold agglutinin disease paroxysmal cold hemoglobinuria . Subject known history Raynaud 's disease , know condition response cold exposure limit blood flow skin . Subject history bleed disorder take medication investigator 's opinion may increase subject 's risk bruising . Subject take take diet pill supplement within past month . Subject dermatological condition , moderate excessive skin laxity , scar location treatment site may interfere treatment evaluation ( stretch mark exclusion ) . Subject active implant device pacemaker , defibrillator , drug delivery system metal contain implant . Subject pregnant intending become pregnant study period Subject lactate lactate past 6 month . Subject history hernia area treat . Subject unable unwilling comply study requirement . Subject currently enrol clinical study unapproved investigational drug device . Any condition laboratory value would , professional opinion investigator , potentially affect subject 's response integrity data would pose unacceptable risk subject .</criteria>
	<gender>All</gender>
	<minimum_age>22 Years</minimum_age>
	<maximum_age>65 Years</maximum_age>
	<verification_date>October 2016</verification_date>
</DOC>